.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Farmers Insurance
Fish and Richardson
Julphar
Federal Trade Commission
Colorcon
Fuji
Accenture
US Army
McKinsey

Generated: September 22, 2017

DrugPatentWatch Database Preview

DEXTROSE 25% Drug Profile

« Back to Dashboard

Which patents cover Dextrose 25%, and when can generic versions of Dextrose 25% launch?

Dextrose 25% is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in DEXTROSE 25% is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.

Summary for Tradename: DEXTROSE 25%

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list11
Clinical Trials: see list137
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEXTROSE 25% at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
DEXTROSE 25%
dextrose
INJECTABLE;INJECTION019445-002Nov 23, 1998RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Colorcon
AstraZeneca
Julphar
Boehringer Ingelheim
Baxter
Chubb
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot